Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-24Clinical Trial Update: A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH [Phase 3]
Phase 3 trial evaluating ralinepag effects on exercise capacity in pulmonary arterial hypertension (PAH) was terminated.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Positioning Imatinib for Pulmonary Arterial Hypertension [Phase 2]
Phase 2 clinical trial exploring imatinib for pulmonary arterial hypertension is in early stages with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 trial of Treprostinil Palmitil Inhalation Powder (TPIP) for pulmonary arterial hypertension has been terminated; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Safety and Efficacy of BIA 5-1058 in PAH [Phase 2]
Phase 2 trial results for BIA 5-1058 in pulmonary arterial hypertension have been completed, reporting safety and efficacy outcomes.
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) [Phase 3]
Phase 3 STELLAR trial evaluating sotatercept for pulmonary arterial hypertension completed with results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial evaluating switched therapy in pulmonary arterial hypertension; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-19Clinical Trial Update: Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST [Phase 3]
A Phase 3 trial of bardoxolone methyl in connective tissue disease-associated pulmonary arterial hypertension was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension [Phase 2]
Phase 2 pediatric dose-confirmation study of selexipag for pulmonary arterial hypertension has posted results; the trial is currently not re…
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 clinical trial update for sotatercept in pulmonary arterial hypertension (PAH) has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Apabetalone for Pulmonary Arterial Hypertension [Phase 2]
Phase 2 clinical trial update for apabetalone in pulmonary arterial hypertension is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) [Phase 2]
Phase 2 trial of ubenimex in pulmonary arterial hypertension has completed; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 clinical trial update for inhaled nitric oxide (INOpulse DS) in pulmonary arterial hypertension (PAH) has completed enrollment/statu…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Long-Term Extension Study of Inhaled Nitric Oxide (iNO) for PAH [Phase 3]
A long-term extension study for inhaled nitric oxide (iNO) in pulmonary arterial hypertension is ongoing (Phase 3).
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension [Phase 2]
Phase 2 clinical trial of sotatercept for pulmonary arterial hypertension has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain [Phase 4]
Phase 4 trial update on lidocaine subcutaneous infusion to control treprostinil-related site pain in pulmonary arterial hypertension.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH [Phase 3]
A Phase 3 trial evaluating pulsed, inhaled nitric oxide vs placebo in symptomatic pulmonary arterial hypertension was terminated; results po…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) [Phase 2]
Open-label extension study of ubenimex in pulmonary arterial hypertension (WHO Group 1) completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 [Phase 2]
Phase 2 pediatric long-term extension study of ambrisentan for hypertension/pulmonary hypertension completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-15Clinical Trial Update: Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension [Phase 4]
Phase 4 trial evaluating the effects of treprostinil on right ventricular structure and function in patients with pulmonary arterial hyperte…
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: ACT-293987 in Pulmonary Arterial Hypertension [Phase 3]
Phase 3 trial of ACT-293987 in Pulmonary Arterial Hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery [Phase 2]
Phase 2 trial update evaluating sitaxsentan dosing in patients undergoing cardiac surgery, including CABG or cardiac valve replacement; stud…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: Management of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial Hypertension [Phase 4]
A Phase 4 clinical trial evaluating management strategies for acute pulmonary hypertensive crisis in children with known pulmonary arterial …
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Efficacy and Safety Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 trial updating efficacy and safety of ambrisentan in Chinese patients with pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension [Phase 3]
An open-label, long-term Phase 3 study evaluating oral treprostinil in subjects with pulmonary arterial hypertension has completed with resu…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Effects of Oral Sildenafil on Mortality in Adults With PAH [Phase 4]
Phase 4 trial evaluating the effects of oral sildenafil on mortality in adults with pulmonary arterial hypertension has been terminated; res…